A-3922

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameA-3922
Drug Alias Namedihydrobenzofuran derivative (Nippon soda)A-3922
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipoxygenase inhibitors
TargetsLipoxygenase
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Soda Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Soda Co Ltd
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A